Metselex, Incorporated
Minneapolis, MN · Biotech · Private
Synthetic metabolic pathway engineered in yeast to produce ursodeoxycholic acid (UDCA) and derivatives
- Grants
- $3.8M
- 5 awards
- Sector median: 1
- Raised
- —
- No Form D on record
- Contracts
- —
- No federal contracts on record
- Patents
- —
- No published records under this name
- Sector median: 2
Capital Timeline
Federal ↑Equity ↓20192020202120222023202420252026
| Date | Event | Source | Amount |
|---|---|---|---|
| Federal grant | Department of Health and Human Services · Phase I · Microbial Synthesis of Therapeutic Bile Acids | $450,234 | |
| Federal grant | Department of Health and Human Services · Phase I · Microbial Synthesis of Therapeutic Bile Acids | $450,234 | |
| Federal grant | Department of Health and Human Services · Phase II · Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease | $1,344,236 | |
| Federal grant | Department of Health and Human Services · Phase II · Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease | $1,280,101 | |
| Federal grant | Department of Health and Human Services · Phase II · Microbial Synthesis of Therapeutic Bile Acids for Alzheimer's Disease | $283,246 |
Federal grant · SBIR/STTR
Peer position
| # | Company | Contracts | Disclosed equity |
|---|---|---|---|
| 2514 | Somite AI | — | — |
| 2515 | Alligator Bioscience AB (publ) | — | $10M |
| 2516 | Prosetta Biosciences Inc. | — | $31M |
| 2517 | Metselex, Incorporated | — | — |
| 2518 | Radionetics Oncology | — | $54M |
| 2519 | SIVEC BIOTECHNOLOGIES, INC. | — | $3.3M |
| 2520 | MOUNTAIN VALLEY MD INC. | — | $18M |
Ranked on federal contract value rather than capital raised. The equity column is the comparison worth making — companies at the same procurement position often sit at very different points in their funding history.
Regulatory activity · Biotech
- New Animal Drugs; Approval of New Animal Drug Applications; Withdrawal of Approval of New Animal Drug Application; Change of SponsorFood and Drug Administration
- Medical Devices; General and Plastic Surgery Devices; Classification of the Skin Patch for Treatment of HyperhidrosisFood and Drug Administration
- Medical Devices; Anesthesiology Devices; Classification of the Monitor for Opioid Induced Impairment of OxygenationFood and Drug Administration
- Medical Devices; Orthopedic Devices; Classification of the Medial Knee Implanted Shock AbsorberFood and Drug Administration
- Medical Devices; Neurological Devices; Classification of the External Lower Extremity Nerve Stimulator for Restless Legs SyndromeFood and Drug Administration
- Medical Devices; General Hospital and Personal Use Devices; Classification of the Infant Supine Sleep SystemFood and Drug Administration
Rules are matched to sector, not to company. Recent activity in a sector is context rather than a signal about this business — until rules are matched to what a company actually builds, the section is shown as context and nothing more.